Location History:
- Nant Peris, GB (2015)
- Gwynedd, GB (2016 - 2020)
- Bangor Gwynedd, GB (2020 - 2021)
Company Filing History:
Years Active: 2015-2021
Title: Christopher David Gwenin: Innovator in Mycobacterial Detection
Introduction
Christopher David Gwenin is a notable inventor based in Gwynedd, GB. He has made significant contributions to the field of medical diagnostics, particularly in the detection of mycobacterial diseases. With a total of six patents to his name, Gwenin's work has the potential to impact public health positively.
Latest Patents
Gwenin's latest patents include innovative methods for determining whether an individual is infected with mycobacterial diseases. One of his patents describes a method that involves providing a system with an antigen, contacting it with a sample from the individual, and detecting the presence or absence of binding of a biomarker in the sample with the antigen. This antigen is an arabinose ester of a mycolic acid or an analogue thereof. Another patent outlines a method for detecting mycobacteria, which includes providing a system with at least two different mycolic-acid derived antigens and introducing a sample from the individual into this system. This method is particularly useful for identifying diseases caused by mycobacterial infections, such as leprosy and pulmonary disease. Additionally, the invention may lead to the development of an over-the-counter device that allows individuals to routinely check their immune responses.
Career Highlights
Throughout his career, Christopher David Gwenin has worked with various organizations, including Diagnostig Ltd. and Bangor University. His experience in these institutions has contributed to his expertise in medical diagnostics and innovation.
Collaborations
Gwenin has collaborated with notable individuals in his field, including Mark Stephen Baird and Vanessa Valerie Gwenin. These collaborations have likely enriched his research and development efforts.
Conclusion
Christopher David Gwenin is a prominent inventor whose work in mycobacterial detection showcases his commitment to advancing medical diagnostics. His innovative patents and collaborations highlight his significant contributions to public health.